Leading Medical Biotechnology Technology (00399.HK): The subscription price has been revised to HKD 0.3124 per share, and trading will resume on July 17th.

The Zhitong Finance APP reported that Leading Medicine Biotechnology (00399.HK) has announced that its shares will resume trading at 9:00 am on July 17, 2025.